|
Ilika PLC on Monday said it has completed the manufacturing process qualification for its Stereax micro-batteries at partner Cirtec Medical Corp’s US facility. The Romsey, England-based solid-state battery technology company said the qualification has been completed for the Stereax M300 micro-battery production line at the facility in Lowell, Massachusetts. This follows the successful equipment commissioning in January and is the final technical validation before the start of production. Ilika said the milestone activates a ten-year manufacturing agreement signed in August 2023, under which Cirtec Medical will produce the Stereax battery portfolio. The first deliveries of M300 batteries to lead customers are targeted to start in 2025. ‘This manufacturing milestone demonstrates the successful technology transfer of our proprietary Stereax platform to commercial production scale,’ said Ilika Chief Executive Officer Graeme Purdy. ‘The strong customer interest we’re seeing validates the market need for miniaturised solid-state batteries in medical devices. With the combination of Ilika’s expertise and Cirtec Medical’s world-class manufacturing capabilities, we are well-positioned to meet growing customer demand in 2025 and beyond.’ Shares in Ilika were up 5.0% at 44.95 pence in London on Monday afternoon. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
